Bevacizumab Plus Nab-paclitaxel and Tegafur Gimeracil Oteracil Potassium Capsule (S-1) as Second-line Treatment for Advanced Biliary Tract Cancer: a Phase Ⅱ Clinical Trial

Clinical trial NCT07719738 · COMPLETED

Trial details

NCT number: NCT07719738
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Cancer Metastatic

Start date: 2026-02-23
Primary completion: 2026-02-23
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.